Table 2. Resting values.
| SCG (n = 24) | CO (n = 11) | ||||||
|---|---|---|---|---|---|---|---|
| Pre SC | Post SC | Pre | Post | Group effect | Time effect | Interaction effect | |
| Days between tests | 48 ± 12 | 44 ± 9 | |||||
| Cotinine (ng mL–1) | 302 ± 119 | n.d. | 360 ± 102 | 381 ± 96 | 0.000* | 0.000* | 0.000* |
| Body mass (kg) | 76.7 ± 10.5 | 78.0 ± 10.8 | 75.0 ± 12.6 | 75.6 ± 12.8 | ns | 0.003* | ns |
| BMI (kg/m2) | 24.3 ± 2.5 | 24.8 ± 2.4 | 23.2 ± 3.0 | 23.4 ± 3.1 | ns | 0.003* | ns |
| Systolic blood pressure (mmHg) | 126 ± 8 | 124 ± 8 | 124 ± 10 | 126 ± 11 | ns | ns | ns |
| Diastolic blood pressure (mmHg) | 70 ± 11 | 67 ± 10 | 74 ± 10 | 68 ± 8 | ns | 0.005* | ns |
| Mean blood pressure | 89 ± 9 | 86 ± 8 | 90 ± 10 | 87 ± 8 | ns | 0.008* | ns |
| Heart rate (beats min–1) | 61 ± 9 | 56 ± 8 | 59 ± 4 | 64 ± 11 | ns | ns | 0.001* |
| Blood lactate (mM L–1) | 1.09 ± 0.33 | 1.00 ± 0.30 | 1.07 ± 0.26 | 1.06 ± 0.30 | ns | ns | ns |
| Blood glucose (mM L–1) | 4.93 ± 0.49 | 5.03 ± 0.49 | 5.11 ± 0.74 | 5.15 ± 0.71 | ns | ns | ns |
| Total cholesterol (mM L–1) | 4.12 ± 0.54 | 4.46 ± 0.70 | 4.64 ± 0.84 | 4.56 ± 0.64 | ns | ns | 0.073 |
| LDL (mM L–1) | 2.37 ± 0.43 | 2.68 ± 0.52 | 2.68 ± 0.80 | 2.57 ± 0.68 | ns | ns | ns |
| HDL (mM L–1) | 1.34 ± 0.29 | 1.35 ± 0.29 | 1.47 ± 0.43 | 1.49 ± 0.41 | ns | ns | 0.029* |
| FFA (mM L–1) | 0.31 ± 0.25 | 0.25 ± 0.14 | 0.20 ± 0.11 | 0.24 ± 0.26 | ns | ns | Ns |
| C-reactive protein (mg L–1) | 1.5 ± 0.6 | 1.4 ± 0.5 | 1.0 ± 0.0 | 1.5 ± 0.7 | ns | ns | ns |
| Insulin (mU L–1) SCG n = 11, CO n = 10 | 46.6 ± 41.2 | 40.5 ± 35.0 | 56.9 ± 37.8 | 98.0 ± 67.1 | 0.093 | 0.023* | 0.003* |
Data are presented as arithmetic mean ± SD.
SCG, snuff cessation group; CO, control group; n.d. = not detectable.
* Significant difference (p<0.05) from RM ANOVA.
ns = no significant difference